Correlation Between Tekla Healthcare and John Hancock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and John Hancock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and John Hancock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tekla Healthcare Opportunities and John Hancock Ii, you can compare the effects of market volatilities on Tekla Healthcare and John Hancock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of John Hancock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and John Hancock.

Diversification Opportunities for Tekla Healthcare and John Hancock

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tekla and John is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Opportunities and John Hancock Ii in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on John Hancock Ii and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Opportunities are associated (or correlated) with John Hancock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of John Hancock Ii has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and John Hancock go up and down completely randomly.

Pair Corralation between Tekla Healthcare and John Hancock

Considering the 90-day investment horizon Tekla Healthcare Opportunities is expected to under-perform the John Hancock. In addition to that, Tekla Healthcare is 1.71 times more volatile than John Hancock Ii. It trades about -0.14 of its total potential returns per unit of risk. John Hancock Ii is currently generating about -0.11 per unit of volatility. If you would invest  1,977  in John Hancock Ii on September 12, 2024 and sell it today you would lose (43.00) from holding John Hancock Ii or give up 2.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tekla Healthcare Opportunities  vs.  John Hancock Ii

 Performance 
       Timeline  
Tekla Healthcare Opp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tekla Healthcare Opportunities has generated negative risk-adjusted returns adding no value to fund investors. Even with relatively invariable technical indicators, Tekla Healthcare is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
John Hancock Ii 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in John Hancock Ii are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, John Hancock may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Tekla Healthcare and John Hancock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tekla Healthcare and John Hancock

The main advantage of trading using opposite Tekla Healthcare and John Hancock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, John Hancock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in John Hancock will offset losses from the drop in John Hancock's long position.
The idea behind Tekla Healthcare Opportunities and John Hancock Ii pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world